SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
Background and Objective. Serine hydroxymethyltransferase 2 (SHMT2) functions as a key enzyme in serine/glycine biosynthesis and one-carbon metabolism. Recent studies have shown that SHMT2 participated in tumor growth and progression in a variety of cancer types. The objective of the present study i...
Saved in:
Main Authors: | Shanglei Ning, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, Yuxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/4369253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiomics and radiogenomics in intrahepatic cholangiocarcinoma
by: A. D. Smirnova, et al.
Published: (2024-03-01) -
Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma
by: Bei-ge Jiang, et al.
Published: (2011-01-01) -
Clinical and magnetic resonance imaging features
predict microvascular invasion in intrahepatic
cholangiocarcinoma
by: Jin-Jun Sun, et al.
Published: (2022-09-01) -
Design of studies on neoadjuvant therapy for intrahepatic cholangiocarcinoma
by: Yuan Cheng, et al.
Published: (2025-01-01) -
Preoperative chemotherapy usage experience for intrahepatic cholangiocarcinoma
by: A. N. Polyakov, et al.
Published: (2023-03-01)